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http://www.biomedcentral.com/1471-2377/14/59RESEARCH ARTICLE Open AccessReversal of English trend towards hospital death
in dementia: a population-based study of place of
death and associated individual and regional
factors, 2001–2010
Katherine E Sleeman1*, Yuen K Ho1, Julia Verne2, Wei Gao1, and Irene J Higginson1 on behalf of the GUIDE_Care projectAbstract
Background: England has one of the highest rates of hospital death in dementia in Europe. How this has changed
over time is unknown. This study aimed to analyse temporal trends in place of death in dementia over a recent ten
year period.
Methods: Population-based study linking Office for National Statistics mortality data with regional variables,
in England 2001–2010. Participants were adults aged over 60 with a death certificate mention of dementia.
Multivariable Poisson regression was used to determine the proportion ratio (PR) for death in care home (1) and
home/hospice (1) compared to hospital (0). Explanatory variables included individual factors (age, gender, marital
status, underlying cause of death), and regional variables derived at area level (deprivation, care home bed
provision, urbanisation).
Results: 388,899 deaths were included. Most people died in care homes (55.3%) or hospitals (39.6%). A pattern of
increasing hospital deaths reversed in 2006, with a subsequent decrease in hospital deaths (−0.93% per year, 95%
CI −1.08 to −0.79 p < 0.001), and an increase in care home deaths (0.60% per year, 95% CI 0.45 to 0.75 p < 0.001).
Care home death was more likely with older age (PR 1.11, 1.10 to 1.13), and in areas with greater care home bed
provision (PR 1.82, 1.79 to 1.85) and affluence (PR 1.29, 1.26 to 1.31). Few patients died at home (4.8%) or hospice
(0.3%). Home/hospice death was more likely in affluent areas (PR 1.23, 1.18 to 1.29), for women (PR 1.61, 1.56 to
1.65), and for those with cancer as underlying cause of death (PR 1.84, 1.77 to 1.91), and less likely in the unmarried
(PRs 0.51 to 0.66).
Conclusions: Two in five people with dementia die in hospital. However, the trend towards increasing hospital
deaths has reversed, and care home bed provision is key to sustain this. Home and hospice deaths are rare.
Initiatives which aim to support the end of life preferences for people with dementia should be investigated.
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Dementia care is a global health priority [1]. There are
over 35 million people worldwide living with dementia,
and this figure is predicted to double by 2030 [2]. In the
United States, the total societal costs of dementia care
are predicted to almost double by 2040 [3]. In Western
Europe the prevalence of dementia is 6.9 per 100 people
over 60, and total costs of dementia care account for an
estimated 1.29% of GDP [2].
Dementia is under-recognised as a terminal illness [4].
Median survival following diagnosis is 2 to 4 years [5,6],
and the trajectory of decline is characterised by progres-
sive functional and cognitive deterioration, with acute
illnesses such as infection frequently precipitating death
[7]. Given the expanding population with the disease,
providing good quality end of life care in dementia is an
enormous challenge [8].
An understanding of where people die is essential to
develop health policies aimed at improving end of life
care. In addition, place of death can be an important in-
dicator of the quality of end of life care [9]. In dementia,
hospitalisation of people nearing the end of their lives
can have a profound detrimental impact, with patients
experiencing problems such as pressure sores, worsening
of behavioural problems, and increased confusion [10].
Reducing the use of hospital-based care in advanced de-
mentia also has potential economic benefits [11].
In the United States, there has been a recent reduction
in hospital deaths, and an increase in home deaths, in
both cancer and dementia [12]. In England, a similar pat-
tern has been shown in cancer, likely in part due to imple-
mentation the National End of Life Care Programme in
the mid-2000s which aimed to enable people to die in
their preferred place (usually home) [13]. However, the
National End of Life Care Strategy has been criticised for
paying inadequate attention to the specific needs of people
with dementia [14]. Data from 2003 showed that England
had one of the highest rates of hospital death and lowest
rates of home death in dementia in Europe [15]. How this
has changed over time is not known. Therefore this study
aimed to examine trends in place of death in dementia in
England, and the individual and regional factors associated
with place of death, over a recent 10 year period.
Methods
Design
Population-based cross-sectional study, 2001–2010 inclusive.
Data sources
Mortality data for all deaths in England 2001–2010 were
obtained from the Office for National Statistics (ONS). By
law, all deaths in England must be registered within five
days (unless a coroner’s inquest is necessary). Mortality
data comprise information recorded on the death certificateincluding the date of death, age and gender of the patient,
and the cause(s) of death, as well as information obtained
by the Registrar’s Office at the time of death registration
including marital status and address of residence. Since
1993 mortality statistics have recorded both the under-
lying cause of death, i.e. the disease that initiated the train
of events leading to death, and contributory causes, de-
fined as part of the causal sequence leading to death or
contributing to death. Where a condition is listed as either
the underlying cause of death, or a contributory cause, this
is termed a mention.
These data were then linked at Lower Super Output Area
(LSOA) level with regional variables including deprivation
quintile, level of urbanisation, and care home bed provision.
The LSOA is a geographic area designed for reporting
small area statistics in England and Wales. There are
32,482 LSOAs in England, with an average population
size of 1,500.Study population
All deaths from 2001–2010 where dementia was men-
tioned, either as the underlying or a contributory cause
of death, were extracted using ICD-10 codes G30 (Alz-
heimers disease), F01 (vascular dementia), F03 (unspeci-
fied dementia) [16]. We chose to study all deaths with a
mention of dementia (rather than only deaths from an
underlying cause of dementia) since dementia is com-
monly a contributory cause of death, and the underlying
cause of death is likely to be associated with place of
death [17]. We focussed on cases aged over 60 (maturity
onset dementia) [18]. Cases where the outcome variable
(place of death) was unknown or classified as ‘other’ (e.g.
in the street) were excluded.Variables
The outcome variable, place of death, was categorised as
care home (includes nursing and residential homes),
home, inpatient hospice (specialist palliative care in-
patient units, either NHS or charitably funded), or hos-
pital (includes NHS and private), based on routinely
used ONS coding categories. Explanatory variables were
individual demographic variables including age at death
(analysed as an ordered categorical variable based on the
data distribution, to aid comparison with previous stud-
ies: 60–79, 80–84, 85–89, 90–94, >95) [15,19], gender
(men, women), marital status (married, single, divorced,
widowed, unknown), year of death (2001–2005, 2006–
2010), and underlying cause of death (grouped into de-
mentia, chronic lower respiratory disease (ICD-10 J40-
47), cancer (ICD-10 C00-97, D00-48), cardiovascular
disease (ICD-10 I00-52, I70-99), cerebrovascular disease
(ICD-10 I60-69), chronic neurological disease (ICD-
10 G12 motor neuron disease, G20 Parkinsons disease,
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10 codes).
Regional variables (derived at LSOA level) were
deprivation quintile (derived from the 2010 Index of
Multiple Deprivation, an area-specific deprivation mea-
sure for LSOAs in England, 1 =most deprived, 5 = least
deprived) [20], level of urbanisation (categorised as urban,
semi-rural and rural based on the 2004 ONS Rural and
Urban Area Classification) [21], and care home bed
provision (information obtained from the Care Quality
Commission in February 2012, analysed as an ordered
categorical variable based on the data distribution: 0, 1–
25, 26–50, >50).Statistical analysis
Percentages were used to describe the study population
in terms of demographic and regional variables. The per-
centage of deaths in care home, hospital, home and in-
patient hospice was standardised using the 2005–2010
mortality structure for more developed countries from
the United Nations standard population [22], in order to
allow comparison over time irrespective of age and gen-
der changes. Trends were inspected visually, and linear
regression with adjustment for age and gender was used
to confirm trends in place of death over the time period.
Multivariable Poisson regression analyses was used to
estimate proportion ratios (PR) for death in care home
(1), or home/hospice (1), compared with hospital (0),
for each of the variables studied. Home and inpatient
hospice were grouped together since preliminary ana-
lyses showed similar trends in place of death for both,
and numbers were small. Poisson regression was chosen
in preference to logistic regression, since odds ratios do
not provide an accurate measure of risk when applied to
common outcomes [23]. A general estimating equation
(GEE) method with exchangeable correlation matrix and
robust 95% confidence intervals (CI) was included to ac-
count for clustering in the data at LSOA level. Explana-
tory variables (age, gender, marital status, underlying cause
of death, IMD quintile, urbanisation, care home bed avai-
lability) were forced to stay in the model. For the home/
hospice model, care home bed availability was not included
as a variable since patients living in care homes would not
be expected to die at home.
Analyses were performed using Stata version 10.Ethics and permission
This study was based on anonymised records, and no
ethical approval was required according to national
guidelines and those of King’s College London Research
Ethics Committee. KS, YKH, WG and IJH were individu-
ally approved by ONS to analyse the data, through the
ONS Data Access Agreement.Results
There were 397,513 deaths with a mention of dementia
recorded in England between 2001 and 2010. These
comprised 6.6% (95% CI 6.5 to 6.7) of all deaths in 2001,
almost doubling to 12.0% (95% CI 11.9 to 12.1) of all
deaths in 2010.
1,733 (0.4%) deaths at age less than 60, and 6,881
deaths with unknown place of death (1.7%), were ex-
cluded, leaving a total of 388,899 deaths included in sub-
sequent analyses. Most deaths were women (66.9%); the
mean age was 85.5 (SD 7.0) years. Most (60.2%) were
widow(er)s, while just over a quarter (27.4%) were mar-
ried. Most patients died in care home (55.3%) or hospital
(39.6%). Very few deaths occurred at home (4.8%) or in-
patient hospices (0.3%). Just under half of all deaths were
certified with dementia as underlying cause of death
(46.5%). These patients were more likely to be women,
older, and die in care homes (Table 1).
People who died at home or in hospice were younger
and more likely to be married than those who died in
care home or hospital. More than half of deaths that oc-
curred in hospice had cancer as underlying cause of
death (Table 2).
As a proportion of all deaths, age and gender adjusted
hospital deaths increased from 37.5% (95% CI 36.9 to
38.0) in 2001 to 45.4% (95% CI 44.9 to 46.0) in 2006
(1.91% per year, 95% CI 1.79 to 2.04 p < 0.001), and sub-
sequently decreased to 40.1% (95% CI 39.6 to 40.5) in
2010 (−0.93% per year, 95% CI −1.08 to −0.79 p < 0.001).
Reciprocally, care home deaths decreased from 57.9%
(95% CI 57.4 to 58.5) in 2001 to 48.8% (95% CI 48.3 to
49.3) in 2006 (−2.06% per year, 95% CI −2.19 to −1.94
p < 0.001), and subsequently increased to 52.6% (95% CI
52.2 to 53.1) in 2010 (0.60% per year, 95% CI 0.45 to
0.75 p < 0.001). Home deaths increased from 4.4% (95%
CI 4.1 to 4.6) in 2001 to 6.7% (95% CI 6.5 to 7.0) in
2010 (0.22% per year, 95% CI 0.20 to 0.25 p < 0.001), and
inpatient hospice deaths increased very slightly from
0.3% (95% CI 0.2 to 0.3) in 2001 to 0.6% (95% CI 0.5 to
0.6) in 2010 (0.03% per year, 95% CI 0.03 to 0.04 p <
0.001) (Figure 1).
Living in an area with more care home beds per 1,000
population was the strongest factor associated with care
home death (PR 1.82, 1.79 to 1.85). Likelihood of care
home death was also higher for those living in affluent
areas (PR 1.29, 1.26-1.31), those living in rural areas (PR
1.17, 1.15 to 1.19), those who were older (PR 1.11, 1.10 to
1.13) and women (PR 1.16, 1.16 to 1.17). Marital status
did not strongly affect the likelihood of care home death.
The likelihood of care home death was lower for four
underlying causes of death: respiratory disease (PR 0.77,
0.75 to 0.79), cardiovascular disease (PR 0.80, 0.79-0.81),
cerebrovascular disease (PR 0.92, 0.91-0.92), and ‘other’
underlying causes of death (PR 0.62, 0.62-0.63) (Table 3).
Table 1 Individual and Regional characteristics of deaths with a mention of dementia (n = 388,899), an underlying
cause of death of dementia (n = 180,905) and an underlying cause of death of non-dementia (n = 207,994) in people
over 60 in England 2001-2010
Variable Value All mentions dementia
(N = 388,899)
Underlying cause of death:
dementia (N = 180,905)
Underlying cause of death:
non-dementia (N = 207,994)
% % %
Gender Men 128,684 33.1 52,194 28.9 76,490 36.8
Women 260,215 66.9 128,771 71.1 131,504 63.2
Age mean (SD) 85.5 (7.0) 86.1 (7.1) 85.1 (6.8)
Age group 60-79 70,987 18.3 29,991 16.6 40,996 19.7
80-84 88,231 22.7 38,152 21.1 50,079 24.1
85-89 113,768 29.3 52,079 28.8 61,689 29.7
90-94 82,543 21.2 41,884 23.2 40,659 19.6
>95 33,370 8.6 18,799 10.4 14,571 7.0
Marital status Married 106,676 27.4 46,337 25.6 60,339 29.1
Single 29,479 7.6 14,008 7.7 15,471 7.44
Widowed 234,024 60.2 112,452 62.2 121,572 48.5
Divorced 16,825 4.3 7,249 4.0 9,576 4.6
Unknown 1,895 0.5 859 0.5 1,036 0.5
Underlying cause of death Dementia 180,905 46.5 180,905 100.0 - -
Respiratory disease 8,662 2.2 - - 8662 4.2
Cancer 19,950 5.1 - - 19,950 9.6
Cardiovascular disease 43,953 11.3 - - 43,953 21.1
Cerebrovascular disease 68,888 17.7 - - 68,888 33.1
Chronic neurological 7,168 1.8 - - 7,168 3.4
Other 59,373 15.3 - - 59,373 28.5
Year of death 2001-2005 166,553 42.8 80,395 44.4 86,158 41.4
2006-2010 222,346 57.2 100,510 55.6 121,836 58.6
Deprivation quintile 1st (most deprived) 72,789 18.7 32,438 17.9 40,351 19.4
2nd 78,982 20.3 36,124 20.0 42,858 20.6
3rd 85,142 21.9 40,165 22.2 44,977 21.6
4th 81,661 21.0 38,503 21.3 43,158 20.8
5th (least deprived) 70,325 18.1 33,675 18.7 36,650 17.6
Urbanisation Urban 309,179 79.5 142,618 78.8 166,561 80.1
Semi-rural 39,967 10.3 19,199 10.6 20,768 10.0
Rural 39,753 10.2 19,088 10.6 20,665 9.9
Care home beds/1,000 0 111,119 28.6 46,025 25.4 65,094 31.3
1-25 75,359 19.4 34,748 19.2 40,611 19.5
26-50 100,413 25.8 49,554 27.4 50,859 24.5
>50 102,008 26.2 50,578 28.0 51,430 24.7
Place of death Care home 215,183 55.3 115,120 63.6 100,063 48.1
Hospital 153,916 39.6 57,086 31.6 96,830 46.6
Home 18,670 4.8 8,489 4.7 10,181 4.9
Inpatient hospice unit 1,130 0.3 210 0.1 920 0.4
SD: standard deviation.
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Table 2 Individual and Regional characteristics of deaths with a mention of dementia occurring in care home (n = 215,183),
hospital (n = 153,916), home (n = 18,670) and inpatient hospice unit (n = 1,130) in people over 60 in England
2001-2010











n % n % n % n % n %
Gender Men 59,571 27.7 62,292 40.5 6,299 33.7 522 46.2 128,684 33.1
Women 155,612 72.3 91,624 59.5 12,371 66.3 608 53.8 260,215 66.9
Age mean (SD) 86.1 (6.9) 84.9 (6.9) 84.3 (7.3) 81.8 (7.4) 85.5 (7.0)
Age group 60-79 34,935 16.2 31,274 20.3 4,378 23.5 400 35.4 70,987 18.3
80-84 46,180 21.5 37,210 24.2 4,538 24.3 303 26.8 88,231 22.7
85-89 62,669 29.1 45,635 29.7 5,197 27.8 267 23.6 113,768 29.3
90-94 49,353 22.9 29,749 19.3 3,311 17.7 130 11.5 82,543 21.2
>95 22,046 10.3 10,048 6.5 1,246 6.7 30 2.7 33,370 8.6
Marital status Married 47,570 22.1 49,925 32.4 8,629 46.2 552 48.9 106,676 27.4
Single 17,441 8.1 11,251 7.3 730 3.9 57 5.0 29,479 7.6
Widowed 139,925 65.0 84,988 55.2 8,665 46.4 446 39.5 234,024 60.2
Divorced 9,209 4.3 6,954 4.5 592 3.2 70 6.2 16,825 4.3
Unknown 1,038 0.5 798 0.5 54 0.3 5 0.4 1,895 0.5
Underlying cause of death Dementia 115,120 53.5 57,086 37.1 8,489 45.5 210 18.6 180,905 46.5
Respiratory disease 3,679 1.7 4,431 2.9 546 2.9 6 0.5 8,662 2.2
Cancer 10,396 4.8 7,038 4.6 1,865 10.0 651 57.6 19,950 5.1
Cardiovascular disease 20,774 9.7 20,539 13.3 2,569 13.8 71 6.3 43,953 11.3
Cerebrovascular disease 38,902 18.1 26,791 17.4 3,092 16.6 103 9.1 68,888 17.7
Chronic neurological 4,137 1.9 2,555 1.7 448 2.4 28 2.5 7,168 1.8
Other 22,175 10.3 35,476 23.1 1,661 8.9 61 5.4 59,373 15.3
Year of death 2001-2005 95,395 44.3 63,900 41.5 6,933 37.1 325 28.8 166,553 42.8
2006-2010 119,788 55.7 90,016 58.5 11,737 62.9 805 71.2 222,346 57.2
Deprivation quintile 1st (most deprived) 35,472 16.5 33,887 22.0 3,213 17.2 217 19.2 72,789 18.7
2nd 42,343 19.7 32,984 21.4 3,435 18.4 220 19.5 78,982 20.3
3rd 48,555 22.6 32,413 21.1 3,945 21.1 229 20.3 85,142 21.9
4th 47,545 22.1 29,684 19.3 4,168 22.3 264 23.4 81,661 21.0
5th (least deprived) 41,268 19.2 24,948 16.2 3,909 20.9 200 17.7 70,325 18.1
Urbanisation Urban 165,574 77.0 128,469 83.5 14,167 75.9 969 85.8 309,179 79.5
Semi-rural 23,757 11.0 14,079 9.2 2,051 11.0 80 7.1 39,967 10.3
Rural 25,852 12.0 11,368 7.4 2,452 13.1 81 7.2 39,753 10.2
Care home beds/1,000 0 36,922 17.2 62,475 40.6 11,103 59.5 619 54.8 111,119 28.6
1-25 39,432 18.3 31,676 20.6 4,003 21.4 248 22.0 75,359 19.4
26-50 65,889 30.6 32,103 20.9 2,271 12.2 150 13.3 100,413 25.8
>50 72,940 33.9 27,662 18.0 1,293 6.9 113 10.0 102,008 26.2
SD: Standard deviation.
Sleeman et al. BMC Neurology 2014, 14:59 Page 5 of 9
http://www.biomedcentral.com/1471-2377/14/59The likelihood of home/hospice death was higher for
women (PR 1.61, 1.56 to 1.65), and lower for those who
were single, widowed or divorced compared to married
(PRs 0.51-0.66). Areas with greater affluence and rural areas
had higher likelihood of home/hospice death (PR 1.23, 1.18to 1.29 and 1.52, 1.46 to 1.59 respectively). The likelihood
of home/hospice death was higher where the underlying
cause of death was cancer (PR 1.84, 1.77 to 1.91) and
neurological disease (PR 1.14, 1.05-1.23). Age had little
effect on likelihood of home/hospice death (Table 3).
Figure 1 Place of death for people with a death certificate mention of dementia in England 2001–2010. Place of death given as
percentage of deaths in care homes, hospital, own residence (home) and hospice with 95% CIs, age and gender-standardised against the UN
mortality standard population [23].
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This population-based study of place of death in demen-
tia in England found that among people with a death
certificate mention of dementia, hospital deaths remain
amongst the highest in developed countries, with two in
five people dying in hospital. However, the trend towards
increasing hospital deaths in dementia reversed in 2006,
with a subsequent fall in hospital deaths between 2006
and 2010, and a reciprocal increase in care home deaths.
Care home bed provision and living in an area of least
deprivation were the most important factors associated
with care home death. Home and inpatient hospice
deaths in dementia are rare, though both have increased
slightly over time. An underlying cause of death of can-
cer, and being married were strongly associated with
home/hospice death.
The reason for the shift from hospital to care home
deaths in dementia is likely to be multifactorial. Policies
such as the Community Care Act (2003), where financial
incentives were introduced to prevent delayed hospital
discharges, may have contributed. The importance of
care home bed provision in promoting care home deaths
is consistent with data from Europe and the United
States [15,19], and there has been an increase in the
number of nursing home beds (though not residential
home beds) in England over this time period [24]. Over-
all, the proportion of hospital deaths in dementia is
lower than the general population in England (58%
2005–2007), and care home deaths are higher in demen-
tia than the general population (16% 2005–2007) [25].
39.6% of people with a death certificate mention of de-
mentia died in hospital. In Europe, hospital deaths in de-
mentia vary from 52.8% (Wales) to 22.8% (Belgium) [15].
In The Netherlands just 3.0% of dementia deaths occur in
hospital, which may be due in part to the presence of specia-
lised nursing home physicians, enabling 90.0% of patients
with dementia to die in care homes [15]. In England andelsewhere the majority of nursing home care is provided by
family physicians. Given the increasing need for high quality
dementia care in care homes, alternative models of care
(such as the Dutch model) should be considered.
Dying at home was rare (4.8% overall), though did in-
crease slightly over the whole time period, suggesting
that implementation of the UK National End of Life
Care Programme in 2004 (a key aim of which was to en-
able people to die at home) had relatively little effect on
home deaths in dementia. In contrast, home deaths in
cancer increased from 22.4 to 25.8% over the same time
period [13]. The UK End of Life Care Strategy (which
was supported by the End of Life Care Programme) has
been criticised for focussing on cancer, and containing
inadequate reference to the growing number of people
dying from dementia [14]. Our data support the need
for initiatives which aim to meet end of life preferences
for people with dementia.
A European study of place of death in dementia using
data from 2003, found that home deaths varied from 3.3%
(Wales) to 16.4% (Belgium) [15]. In the United States,
home deaths in dementia are more common: home deaths
increased from 19.9% in 2000 to 22.8% in 2009 in a cohort
of Medicare beneficiaries with dementia [12], which coin-
cided with an increase in use of the hospice benefit (com-
munity-based specialist palliative care) amongst this
population from 19.5% to 48.3%. Enrolment in a hospice
program has been shown to increase the likelihood of
home death (and reduce hospital deaths) in patients with
dementia in the United States [26], but whether commu-
nity specialist palliative care support is an important factor
enabling home deaths in dementia in England requires ex-
ploration. In England, community specialist palliative care
input in dementia is currently uncommon [27], being
most often associated with cancer. Accordingly, one of
the strongest factors associated with home death in
our study was an underlying cause of death of cancer.
Table 3 Multivariable analysis: association of individual and regional characteristics with place of death (Care Home v
Hospital and Home/Hospice v Hospital) in England 2001–2010
Variable Value Care home v Hospital Home/hospice v Hospital
PR Lower 95% CI Upper 95% CI PR Lower 95% CI Upper 95% CI
Age group 60-79 1.00 - - 1.00 - -
80-84 1.00 0.99 1.01 0.92 0.88 0.95
85-89 1.01 1.00 1.02 0.90 0.87 0.94
90-94 1.05 1.04 1.06 0.94 0.91 0.98
>95 1.11 1.10 1.13 1.05 0.99 1.11
Gender Women v Men 1.16 1.16 1.17 1.61 1.56 1.65
Marital status Married 1.00 - - 1.00 - -
Single 1.01 1.00 1.02 0.51 0.48 0.55
Divorced 0.97 0.95 0.98 0.65 0.60 0.69
Widowed 1.01 1.00 1.02 0.66 0.64 0.68
Unknown 1.03 0.99 1.07 0.59 0.47 0.74
Year of death 2001-2005 1.00 - - 1.00 - -
2006-2010 0.96 0.96 0.97 1.24 1.20 1.27
IMD quintile 1st (most deprived) 1.00 - - 1.00 - -
2nd 1.10 1.08 1.12 1.04 1.00 1.09
3rd 1.17 1.14 1.19 1.09 1.04 1.14
4th 1.21 1.19 1.24 1.16 1.11 1.22
5th (most affluent) 1.29 1.26 1.31 1.23 1.18 1.29
Urbanisation Urban 1.00 - - 1.00 - -
Semi-rural 1.10 1.08 1.12 1.12 1.07 1.17
Rural 1.17 1.15 1.19 1.52 1.46 1.59
Care home beds per 1000 0 1.00 - - - - -
1-25 1.35 1.32 1.37 - - -
26-50 1.68 1.65 1.70 - - -
51-250 1.82 1.79 1.85 - - -
Underlying cause of death Dementia 1.00 - - 1.00 - -
Respiratory 0.77 0.75 0.79 0.87 0.80 0.94
Cancer 1.00 0.98 1.01 1.84 1.77 1.91
Cardiovascular 0.80 0.79 0.81 0.86 0.82 0.89
Cerebrovascular 0.92 0.91 0.92 0.80 0.77 0.83
Neurological 1.01 1.00 1.03 1.14 1.05 1.23
Other 0.62 0.62 0.63 0.38 0.36 0.39
PR: proportion ratio.
PRs were estimated from Poisson regression models. The clustering effect within the LSOA geographical units was adjusted using the general estimating equation
(GEE) method. A PR greater than 1 indicates higher probability of death in a care home or home/hospice.
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marriage, which is consistent with studies in cancer
and non-cancer [13,28], and indicates the importance
of social support in facilitating home death.
In England, inpatient hospice units have been integral
to the development of palliative care provision, and
there are now 223 adult hospices in England providing
inpatient and community care. In this study, very few
people with a death certificate mention of dementia diedin inpatient hospice units (0.3%, compared to 5% overall
in England 2005–2007 [25]), and over half of hospice
deaths in our study occurred in people who had an
underlying cause of death of cancer. It is important to
appreciate that this study can provide no information on
the number of people with dementia who received sup-
port from specialist palliative care teams in the commu-
nity (for example at home, or in care homes), though
national data suggests fewer than 2% of people seen by
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mentia (compared with 80% with cancer diagnoses) [29].
The association between hospice death and cancer is
consistent with previous studies [17].
In contrast to previous investigations of place of death
in dementia [15,19], we studied all deaths with a mention
of dementia, rather than only deaths from an underlying
cause of dementia. More than half of deaths in the popula-
tion were coded with an underlying cause other than de-
mentia, and underlying cause of death was strongly
associated with place of death. By using any mention of
dementia, deaths from acute unforeseen events are in-
cluded, which is important since these are patients in
whom advance care planning can be most useful. It is im-
portant to be aware that a death certificate mention of de-
mentia indicates that dementia was sufficiently advanced
to contribute to death, whether or not it was the under-
lying cause. In cases where dementia had been diagnosed
but was not thought to contribute to death, it would not
be expected to appear on the death certificate.
This study used a whole population data set, allowing
analysis of place of death, not limited by national gene-
ralisability. However, mortality data are limited by the
number of variables available for analysis. For example,
there was no information available on preference for
place of death, trajectory of decline, symptom burden, or
ethnicity, all of which influence place of death [28,30].
There was no information on health care transitions, ag-
gressiveness of end of life care, or overall quality of care.
Studies using mortality statistics are susceptible to
certification bias [31]. Dementia is known to be in-
completely diagnosed in the UK, and even where it is
diagnosed, it is underreported on death certificates. In
one study dementia was not mentioned on the death
certificate in 37% of people with known advanced de-
mentia [32]. The influence of setting on death certifi-
cation is unclear, though there is evidence that those
who die in care homes are more likely to be certified
with dementia as a cause of death, compared to other
places of death [33]. Incentives to identify dementia as
part of the primary care Quality and Outcomes Frame-
work (QOF) may have increased certification of de-
mentia over time, particularly amongst decedents in
care homes where the majority of care is provided by
general practitioners. For these reasons, care must be
taken in interpretation that these data relate to people
with a death certificate mention of dementia, rather
than to the whole population.
Conclusions
End of life care for the growing population with dementia
is a public health priority. This study has provided high
quality empirical data on where people with a death certifi-
cate mention of dementia die, and information regardingthe factors associated with place of death, to inform health
policies and planning. Important considerations for com-
missioners, policy makers and researchers are:
1. Home deaths remain extremely rare amongst people
with a death certificate mention of dementia. Home
palliative care services have been shown in meta-
analysis to increase the odds of home death in can-
cer [34], but evidence in dementia is sparse [35], and
high quality randomised controlled trials are needed.
2. Deaths amongst people with a death certificate
mention of dementia in England have started to shift
from hospitals to care homes. If this is to be
maintained, care home bed provision must increase in
line with the projected increase in dementia deaths.
3. Improved death certification is essential to fully
understand place of death in dementia. The extent
to which dementia certification practices are
associated with place of death is unclear, and
requires further exploration. Future studies using
mortality statistics to explore place of death in
dementia should take into consideration changes in
certification practices over time.
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